UBS Group AG - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 42 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$72,005
+181.8%
12,163
+349.8%
0.00%
Q1 2023$25,553
-25.8%
2,704
-16.4%
0.00%
Q4 2022$34,453
+165.0%
3,235
+76.2%
0.00%
Q3 2022$13,0001,836
+5000.0%
0.00%
Q2 2022$036
-28.0%
0.00%
Q4 2021$0
-100.0%
50
-66.7%
0.00%
Q3 2021$1,000
-95.5%
150
-94.7%
0.00%
Q2 2021$22,000
+2100.0%
2,843
+1795.3%
0.00%
Q1 2021$1,0001500.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sentinus, LLC 149,050$1,408,5230.47%
Intrepid Financial Planning Group LLC 19,000$179,5500.09%
PERRITT CAPITAL MANAGEMENT INC 12,000$113,4000.06%
Interchange Capital Partners, LLC 11,413$107,8530.06%
Virtu Financial LLC 21,650$2050.02%
CREATIVE FINANCIAL DESIGNS INC /ADV 15,000$141,7500.02%
J. Goldman & Co LP 42,228$399,0550.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 63,966$604,4790.02%
KENNEDY CAPITAL MANAGEMENT LLC 46,311$437,6390.01%
683 Capital Management, LLC 16,000$151,2000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders